Apple’s long-running legal dispute with Masimo over the blood oxygen feature in its smartwatches has taken another turn, following a new ruling from a US trade judge.
Masimo previously secured a decision that Apple had infringed its pulse oximetry patents, which led to an import ban on certain Apple Watch models in the US.
